TREA

98957449 - ARGENX

Follow

Information

  • Trademark
  • 98957449
  • Serial Number
    98957449
  • Filing Date
    January 13, 2025
    a year ago
  • Transaction Date
    June 20, 2025
    9 months ago
  • Status Date
    June 19, 2025
    9 months ago
  • Location Date
    June 19, 2025
    9 months ago
  • First Use Anywhere Date
    December 17, 2021
    4 years ago
  • First Use In Commerce Date
    December 17, 2021
    4 years ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 114
    Employee Name
    CHHINA, KARAN
  • Attorney Docket Number
    096680.0015
    Attorney Name
    Edward T. White
    Law Office Assigned Location Code
    M50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ARGENX
Case File Statements
  • AF0421: The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0422: The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0351: The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
  • GS0051: Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
  • AF0052: The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0352: The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0441: The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0051: The mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
  • AF0442: The mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
  • GS0351: Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; Administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs
  • GS0441: Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; Provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network
  • GS0421: Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development
Case File Event Statements
  • 1/13/2025 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/19/2025 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/19/2025 - 9 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/19/2025 - 9 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/19/2025 - 9 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/11/2025 - 9 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS